Imagine losing your child to cancer because her symptoms were dismissed simply because she was young. This is the heartbreaking reality for Mark and Michelle Sneddon, whose 17-year-old daughter, Isla, passed away in March 2025, just six months after being diagnosed with breast cancer. But here's where it gets controversial: they believe Isla’s life could have been saved if she had been treated with the same urgency as an adult. And this is the part most people miss: Isla’s story isn’t just a tragedy—it’s a call to action to overhaul how pediatric cancer cases are handled.
Isla’s journey began in July 2022 when she visited her GP with a lump in her breast. She was told it was likely benign, attributed to hormonal changes, and that she would “grow out of it.” Fast forward two years, and Isla’s condition worsened, leading to an urgent referral for biopsies. Yet, her parents claim the referral was downgraded to routine due to her age, delaying her diagnosis until the cancer had spread to her lungs, lymph nodes, and the lining of her heart. Here’s the kicker: by the time Isla was diagnosed, she had just six months to a year left to live.
Mark and Michelle are now advocating for Isla’s Law, a proposed change in Scottish legislation to ensure children and young people receive the same urgent care and diagnostic access as adults. They also demand a formal review of pediatric diagnostic delays to identify systemic failures. But here’s the controversial question: Are current medical guidelines failing young patients by underestimating the severity of their symptoms simply because of their age?
Michelle points out that Isla’s symptoms, like anxiety and chest infections, were often dismissed as typical teenage issues. Later, they learned these were signs of her cancer. She argues that when a child presents with multiple symptoms, GPs should deviate from standard guidelines and explore alternative pathways. Think about it: If Isla’s case had been investigated further with tests like mammograms or scans, could her life have been saved?
While NHS Lanarkshire maintains that Isla’s treatment followed expected clinical pathways, her parents insist that her case was an outlier—a rare cancer that slipped through the cracks. They’re not just grieving; they’re fighting to prevent other families from enduring their pain. Here’s another thought-provoking question: How many more young lives are at risk because their symptoms are brushed off as age-related?
The Sneddons are set to meet with Health Secretary Neil Gray to discuss their concerns, but they’ve been told any legislative change will have to wait until a new government is formed. Meanwhile, the Scottish government has updated cancer referral guidelines, including a new pathway for children and young people. But is this enough? We want to hear from you: Do you think pediatric cancer care needs a radical overhaul, or are current measures sufficient? Share your thoughts in the comments below.
